[HTML][HTML] Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
Y Yataghène, PL Etienne, P Michel, B Lamezec… - British journal of …, 2010 - nature.com
Background: Concurrent chemoradiotherapy is a valuable treatment option for localised
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
[引用][C] Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
T CONROY, Y YATAGHENE, E RIO… - British journal of …, 2010 - pascal-francis.inist.fr
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil
in oesophageal cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
in oesophageal cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer.
T Conroy, Y Yataghène, PL Etienne… - British Journal of …, 2010 - search.ebscohost.com
Abstract < bold> Background: </bold> Concurrent chemoradiotherapy is a valuable
treatment option for localised oesophageal cancer (EC), but improvement is still needed. A …
treatment option for localised oesophageal cancer (EC), but improvement is still needed. A …
[PDF][PDF] Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
T Conroy, Y Yataghene, PL Etienne, P Michel… - British Journal of …, 2010 - academia.edu
BACKGROUND: Concurrent chemoradiotherapy is a valuable treatment option for localised
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
T Conroy, Y Yataghène, PL Etienne, P Michel… - British Journal of …, 2010 - hal.univ-smb.fr
Background: Concurrent chemoradiotherapy is a valuable treatment option for localised
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
[PDF][PDF] Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
T Conroy, Y Yataghene, PL Etienne, P Michel… - British Journal of …, 2010 - Citeseer
BACKGROUND: Concurrent chemoradiotherapy is a valuable treatment option for localised
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
[HTML][HTML] Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
T Conroy, Y Yataghène, PL Etienne… - British Journal of …, 2010 - ncbi.nlm.nih.gov
Background: Concurrent chemoradiotherapy is a valuable treatment option for localised
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
T Conroy, Y Yataghène, PL Etienne… - British journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
Background Concurrent chemoradiotherapy is a valuable treatment option for localised
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
T Conroy, Y Yataghène, PL Etienne, P Michel… - British Journal of …, 2010 - hal.science
Background: Concurrent chemoradiotherapy is a valuable treatment option for localised
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
[PDF][PDF] Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer
T Conroy, Y Yataghene, PL Etienne… - British Journal of …, 2010 - researchgate.net
BACKGROUND: Concurrent chemoradiotherapy is a valuable treatment option for localised
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …
oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was …